Antony, France

Vi-Thuy Dao

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Vi-Thuy Dao: Innovating Cancer Treatment with Gossypol Derivatives**

Introduction

Vi-Thuy Dao is a notable inventor based in Antony, France, recognized for her innovative contributions in the field of pharmaceuticals. With a keen focus on cancer treatment, her work has the potential to significantly alter therapeutic approaches for patients.

Latest Patents

Vi-Thuy Dao holds a patent for "Gossypol derivatives, production method thereof and uses of same." This patent describes compounds of a general formula (1) and emphasizes their pharmaceutical properties. In particular, the invention consists of innovative compositions that offer promising avenues for cancer treatment.

Career Highlights

Throughout her career, Vi-Thuy Dao has been associated with esteemed research institutions, including the Centre National de la Recherche Scientifique (CNRS) and the Institut National de la Santé et de la Recherche Médicale (INSERM). Her tenure at these institutions has enabled her to explore groundbreaking research that intersects medicine and science.

Collaborations

Vi-Thuy has collaborated with fellow researchers and distinguished colleagues throughout her career, including Jean De Gunzburg and Robert Michelot. These collaborations have fostered an environment of creativity and led to significant advancements in the understanding of pharmaceutical compounds.

Conclusion

With her innovative approach and extensive research experience, Vi-Thuy Dao continues to contribute meaningfully to the field of medicine. Her patent on Gossypol derivatives not only highlights her ingenuity but also showcases her commitment to improving treatment options for cancer patients. The ongoing developments in her research promise to enhance the landscape of pharmacological therapies, making her a key figure in the pursuit of more effective cancer treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…